{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:19:29Z","timestamp":1783171169271,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J011252"],"award-info":[{"award-number":["2023J011252"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J01223"],"award-info":[{"award-number":["2025J01223"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111534","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:57:36Z","timestamp":1776074256000},"page":"111534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Individualized risk-adapted cranial border for nodal clinical target volume in nasopharyngeal carcinoma: challenging the universal skull base rule"],"prefix":"10.1016","volume":"220","author":[{"given":"Zhiwei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-507X","authenticated-orcid":false,"given":"Jihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianji","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4091-8014","authenticated-orcid":false,"given":"Qiaojuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111534_b0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2025.05.019","article-title":"International consensus guideline on delineation of the clinical target volumes at different dose levels for nasopharyngeal carcinoma (2024 Version)","volume":"123","author":"Lin","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111534_b0010","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/S1470-2045(25)00327-4","article-title":"Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas","volume":"26","author":"Tang","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111163","article-title":"A predictive model based on the dosimetric parameters of the parotid stem cell region to assess the recovery of radiation-induced xerostomia in long-term survivors of nasopharyngeal carcinoma after radical radiotherapy","volume":"213","author":"Zhang","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"102","author":"McDowell","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111534_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.24150","article-title":"Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy","volume":"38","author":"Huang","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2026.111534_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109683","article-title":"Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients","volume":"184","author":"Zhao","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0040","article-title":"Treatment deescalation strategies for nasopharyngeal cancer: a review","author":"Lee","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2021.05.020","article-title":"Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC)","volume":"161","author":"Jiang","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2008.07.014","article-title":"Patterns of level II node metastasis in nasopharyngeal carcinoma","volume":"89","author":"Wang","year":"2008","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2015.02.017","article-title":"Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels","volume":"115","author":"Wang","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0065","doi-asserted-by":"crossref","unstructured":"Gr\u00e9goire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 2014;110:172\u201381. Doi: 10.1016\/j.radonc.2013.10.010.","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"10.1016\/j.radonc.2026.111534_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13014-014-0264-9","article-title":"Technical guidelines for head and neck cancer IMRT on behalf of the italian association of radiation oncology - head and neck working group","volume":"9","author":"Merlotti","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0080","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/s12885-024-12391-7","article-title":"Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2026.111534_b0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13014-020-01720-2","article-title":"Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"15","author":"Wang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0095","doi-asserted-by":"crossref","unstructured":"Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ, et al. Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 2016;122. Doi: 10.1002\/cncr.29795.","DOI":"10.1002\/cncr.29795"},{"key":"10.1016\/j.radonc.2026.111534_b0100","doi-asserted-by":"crossref","DOI":"10.1148\/radiology.177.2.2217772","article-title":"Cervical lymph node metastasis: assessment of radiologic criteria","volume":"177","author":"van den Brekel","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2026.111534_b0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2020.12.035","article-title":"Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: a prospective observation series","volume":"156","author":"Guo","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2024.12.002","volume":"122","author":"Guo","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111534_b0115","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0125","first-page":"267","article-title":"Nasopharyngeal carcinoma intensity modulated radiotherapy target and dose design guidelines: expert consensus","volume":"20","author":"Chinese Society of Radiation Oncology","year":"2011","journal-title":"Chin J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0130","article-title":"NRG-HN001: Randomized phase II and phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)","author":"Oncology","year":"2021","journal-title":"[Internet] ClinicalTrialsgov"},{"key":"10.1016\/j.radonc.2026.111534_b0135","unstructured":"Chinese Medical Doctor Association, Chinese Medical Association. 2020 Chinese guidelines for radiotherapy of nasopharyngeal carcinoma. Chin J Cancer Prev Treat. 2021;28(4):167-77."},{"key":"10.1016\/j.radonc.2026.111534_b0140","unstructured":"Chinese Society of Clinical Oncology (CSCO). Guidelines of Chinese Society of Clinical Oncology (CSCO): nasopharyngeal carcinoma. Beijing: People\u2019s Medical Publishing House; 2025."},{"key":"10.1016\/j.radonc.2026.111534_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111534_b0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2021.12.032","article-title":"Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline","volume":"167","author":"Guo","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111534_b0155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:45:00Z","timestamp":1783169100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S0167814026003737"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111534","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized risk-adapted cranial border for nodal clinical target volume in nasopharyngeal carcinoma: challenging the universal skull base rule","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111534"}}